Terms: = Lymphoma AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
16 results:
1. [Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases].
Zheng YY; Xie JL; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1144-1150. PubMed ID: 37899321
[No Abstract] [Full Text] [Related]
2. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
[No Abstract] [Full Text] [Related]
3. Treatment of extranodal NK/T-cell lymphoma: From past to future.
Yan Z; Yao S; Wang Z; Zhou W; Yao Z; Liu Y
Front Immunol; 2023; 14():1088685. PubMed ID: 36825002
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological features of angioimmunoblastic T-cell lymphoma pattern Ⅰ].
Lu HD; Xie JL; Zhang LN; Zheng YY; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):856-860. PubMed ID: 36097902
[No Abstract] [Full Text] [Related]
5. Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.
Calvani J; de Masson A; de Margerie-Mellon C; de Kerviler É; Ram-Wolff C; Gruber A; Meignin V; Brice P; Sadoux A; Mourah S; Bagot M; Battistella M
Br J Dermatol; 2021 Aug; 185(2):419-427. PubMed ID: 33400272
[TBL] [Abstract] [Full Text] [Related]
6. Predicting treatment response of patients with extranodal natural killer/T-cell lymphoma based on levels of PD-L1 mRNA and soluble PD-L1.
Feng Y; Jing C; Yu X; Cao X; Xu C
Hematol Oncol; 2020 Oct; 38(4):467-477. PubMed ID: 32515093
[TBL] [Abstract] [Full Text] [Related]
7. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract] [Full Text] [Related]
8. [Effect of pd-1, FOXP3 and CSF-1R Protein Expression on the Prognosis of Patients with Hodgkin's lymphoma].
Li XJ; He L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1372-1377. PubMed ID: 30295253
[TBL] [Abstract] [Full Text] [Related]
9. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract] [Full Text] [Related]
10. Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy.
Sidhu P; Menzies AM; Long G; Carlino M; Lorens S; Kapoor R
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):759-766. PubMed ID: 29024572
[TBL] [Abstract] [Full Text] [Related]
11. The changing diagnostic pathway for lung cancer patients in Shanghai, China.
Jiang T; Ren S; Li X; Su C; Zhou C; O'Brien M
Eur J Cancer; 2017 Oct; 84():168-172. PubMed ID: 28822887
[TBL] [Abstract] [Full Text] [Related]
12. [New therapy outlooks in Hodgkin lymphoma].
Rossi C; Casasnovas RO
Bull Cancer; 2017 Feb; 104(2):182-194. PubMed ID: 28088309
[TBL] [Abstract] [Full Text] [Related]
13. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of pd-1 and TIM-3 on CD3+ T cells from diffuse large B-cell lymphoma.
Zhang L; Du H; Xiao TW; Liu JZ; Liu GZ; Wang JX; Li GY; Wang LX
Biomed Pharmacother; 2015 Oct; 75():83-7. PubMed ID: 26463635
[TBL] [Abstract] [Full Text] [Related]
15. Utility of cd279/pd-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates.
Cogbill CH; Swerdlow SH; Gibson SE
Am J Clin Pathol; 2014 Jul; 142(1):88-98. PubMed ID: 24926091
[TBL] [Abstract] [Full Text] [Related]
16. Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face.
Li JY; Guitart J; Pulitzer MP; Subtil A; Sundram U; Kim Y; Deonizio J; Myskowski PL; Moskowitz A; Horwitz S; Querfeld C
Am J Dermatopathol; 2014 May; 36(5):402-8. PubMed ID: 24394306
[TBL] [Abstract] [Full Text] [Related]
